AI-generated content for informational purposes only. Not financial advice. Always do your own research.

Over

Wereldwijd wellnessbedrijf (voorheen Weight Watchers) dat gewichtsbeheerprogramma's aanbiedt met digitale hulpmiddelen, coaching en klinische interventies waaronder GLP-1-ondersteuning.

Afslankaandelen

WW International (voorheen Weight Watchers) is een wereldwijd wellnessbedrijf dat gewichtsbeheerprogramma's aanbiedt via digitale hulpmiddelen, coaching en klinische oplossingen, zich aanpassend aan het GLP-1-geneesmiddelen-tijdperk.

Key Financials WW

Prijs $23.22
Wijziging (1D) +0.96%
Wijziging (30D) -20.52%
Wijziging (60D) -5.95%
Wijziging (90D) -13.13%
P/E-verhouding 2.03
EPS (TTM) $11.43
52-weekse bandbreedte $18.00 — $46.95
50-daags MA $25.58
Volume 162.4K

Data updated Feb 15 · Source: Twelve Data

2.8
1 reviews
Valuation
3.2
Management Quality
3
Fundamentals
2.8
Risk Profile
2.5
Performance
2.2
Claude Opus 4.6
AI Review
2.8/5

WW International faces a pivotal moment as the weight loss industry undergoes seismic disruption from GLP-1 medications like Ozempic and Wegovy. The company has attempted to pivot by incorporating clinical weight management services, including prescribing GLP-1 drugs through its acquired telehealth platform, but execution remains uncertain. The stock trades at a remarkably low P/E of 2.03 with EPS of $11.43, though these figures likely reflect one-time items rather than sustainable earnings power, warranting skepticism. Trading at roughly half its 52-week high of $46.95 and well below its 50-day moving average, the technical picture is bearish with a 20.5% decline over 30 days. The bull case centers on WW's massive brand recognition, loyal subscriber base, and potential to become a hybrid behavioral-clinical weight management platform. The bear case is formidable: declining core membership, heavy debt load, and competition from pharma companies and digital health startups that could render the traditional points-based model obsolete. The company's turnaround strategy requires significant investment while revenues remain under pressure. High-risk, speculative opportunity for contrarian investors.

Valuation
3.2
Management Quality
3
Fundamentals
2.8
Risk Profile
2.5
Performance
2.2
Feb 15, 2026
WW International Screenshot

Added: Feb 15, 2026

weightwatchers.com

Latest from Otrai